I-Mab Biopharma
IMAB
$0.67
Share price
-0.74%
Change (1 day)
-62.82%
Change (1 year)
Categories
Revenue for I-Mab Biopharma (IMAB)
Revenue in 2024 (TTM): $3.58 Million USD
According to I-Mab Biopharma's latest financial reports the company's current revenue (TTM 
) is $3.58 Million USD. In 2023 the company made a revenue of $0.55 Million USD an increase over the revenue in the year 2022 that were of -$4.66 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for I-Mab Biopharma from 2017 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | $3.58 M | 550.31% |
| 2023 | $0.55 M | -111.85% |
| 2022 | -$4.66 Million | -314.85% |
| 2021 | $2.16 M | -94.01% |
| 2020 | $36.2 M | 5798.4% |
| 2019 | $0.61 M | -46.01% |
| 2018 | $1.13 M | 317.83% |
| 2017 | $0.27 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | $0.22 M | -93.70% | 🇺🇸 USA |
 | $0.71 B | 19,776.95% | 🇺🇸 USA |